[
  {
    "ts": null,
    "headline": "Reasons to Retain Avanos Medical Stock in Your Portfolio Now",
    "summary": "AVNS's solid Q2 performance, strong product demand, and strategic transformation support growth amid tariff and FX headwinds.",
    "url": "https://finnhub.io/api/news?id=51859f0f156c5e7171cd8472e4debb52a0cbd8a7de804ab6ee618b4f97e1ea55",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757525700,
      "headline": "Reasons to Retain Avanos Medical Stock in Your Portfolio Now",
      "id": 136689246,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "AVNS's solid Q2 performance, strong product demand, and strategic transformation support growth amid tariff and FX headwinds.",
      "url": "https://finnhub.io/api/news?id=51859f0f156c5e7171cd8472e4debb52a0cbd8a7de804ab6ee618b4f97e1ea55"
    }
  },
  {
    "ts": null,
    "headline": "Dentsply Sirona Retains Wellspect Following Strategic Review",
    "summary": "XRAY will keep its Wellspect unit, betting on its strong cash flows and $2B market to deliver greater long-term shareholder value.",
    "url": "https://finnhub.io/api/news?id=9ffdda3b30450fddedc98ac34deed35d2bf5e7bb7bff974a05954c7d2fe340a5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757512920,
      "headline": "Dentsply Sirona Retains Wellspect Following Strategic Review",
      "id": 136690898,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "XRAY will keep its Wellspect unit, betting on its strong cash flows and $2B market to deliver greater long-term shareholder value.",
      "url": "https://finnhub.io/api/news?id=9ffdda3b30450fddedc98ac34deed35d2bf5e7bb7bff974a05954c7d2fe340a5"
    }
  }
]